
Kringle
4884.TKringle Pharma, Inc. Price (4884.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
6,399,270
(18.7203)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $471-1328
- Market Cap 5.78B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Kiichi Adachi Ph.D.
- IPO Date: December, 28, 2020
- Country: JP
- Currency: JPY
- Headquaters: No Data
- Employees: 15
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
